Compare HEPS & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HEPS | EVO |
|---|---|---|
| Founded | 2000 | 1993 |
| Country | Turkey | Germany |
| Employees | N/A | 4553 |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 948.0M | 934.1M |
| IPO Year | 2021 | N/A |
| Metric | HEPS | EVO |
|---|---|---|
| Price | $2.68 | $2.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.07 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 266.4K | 97.0K |
| Earning Date | 05-07-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $41.29 | $1.37 |
| Revenue Next Year | $27.99 | $10.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.15 | $2.31 |
| 52 Week High | $3.30 | $4.80 |
| Indicator | HEPS | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 47.30 |
| Support Level | $2.66 | $2.88 |
| Resistance Level | $2.95 | $3.78 |
| Average True Range (ATR) | 0.07 | 0.12 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 7.50 | 13.73 |
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.